ORIGINAL RESEARCH
Accepted on 09 Jul 2025
Combining the DNA methylation markers of circulating tumor cells with immune infiltrating cells to assess recurrence and prognosis and to suggest a therapeutic strategy in Stage III-IV colorectal cancer
doi 10.3389/fimmu.2025.1607548